These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25289407)

  • 1. FDA issues guidance on regulation of cell-based products in animals.
    J Am Vet Med Assoc; 2014 Sep; 245(5):474. PubMed ID: 25289407
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA finalizes guidance on cell-based products in animals.
    Cima G
    J Am Vet Med Assoc; 2015 Jul; 247(2):132. PubMed ID: 26349092
    [No Abstract]   [Full Text] [Related]  

  • 3. HSUS sues FDA to end preventive extralabel use.
    Nolen S
    J Am Vet Med Assoc; 1999 Jun; 214(11):1607. PubMed ID: 10363086
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA backs legislation to restrict antimicrobial use.
    Cima G
    J Am Vet Med Assoc; 2009 Sep; 235(5):493-5. PubMed ID: 19731457
    [No Abstract]   [Full Text] [Related]  

  • 5. United States Food and Drug Administration Regulation of Gene and Cell Therapies.
    Bailey AM; Arcidiacono J; Benton KA; Taraporewala Z; Winitsky S
    Adv Exp Med Biol; 2015; 871():1-29. PubMed ID: 26374210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senators doubt FDA can control antimicrobial use.
    Cima G
    J Am Vet Med Assoc; 2015 Feb; 246(4):387. PubMed ID: 25796647
    [No Abstract]   [Full Text] [Related]  

  • 7. Has the Food and Drug Administration abused its authority in attempting to regulate veterinary compounding?
    Siegner AW
    J Am Vet Med Assoc; 1994 Jul; 205(2):243-7. PubMed ID: 7928589
    [No Abstract]   [Full Text] [Related]  

  • 8. The regulation of veterinary regenerative medicine and the potential impact of such regulation on clinicians and firms commercializing these treatments.
    Nobert KM
    Vet Clin North Am Equine Pract; 2011 Aug; 27(2):383-91. PubMed ID: 21872766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA rejects extra-label drug use proposal.
    J Am Vet Med Assoc; 1983 Nov; 183(9):929. PubMed ID: 12002580
    [No Abstract]   [Full Text] [Related]  

  • 10. Mesenchymal stem-cell therapy in a regulated environment.
    Gee A
    Cytotherapy; 2001; 3(5):397-8. PubMed ID: 11953020
    [No Abstract]   [Full Text] [Related]  

  • 11. Extralabel drug use in aquaculture.
    Stull G
    J Am Vet Med Assoc; 1999 Oct; 215(8):1091-2. PubMed ID: 10530319
    [No Abstract]   [Full Text] [Related]  

  • 12. The reformation of animal drug law: the impact of 1996.
    Lambert EI
    Food Drug Law J; 1997; 52(3):277-89. PubMed ID: 10343026
    [No Abstract]   [Full Text] [Related]  

  • 13. Lawmakers mull over minor use/minor species bill.
    Nolen RS
    J Am Vet Med Assoc; 2000 Aug; 217(4):460-1. PubMed ID: 10953701
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of FDA-approved drugs in veterinary medicine: prerogatives and responsibilities.
    Mann CJ
    J Am Vet Med Assoc; 1993 May; 202(10):1674-7;discussion 1684-92. PubMed ID: 8514581
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA veterinary notes.
    Knobloch CP
    J Am Vet Med Assoc; 1979 Jul; 175(1):44. PubMed ID: 500432
    [No Abstract]   [Full Text] [Related]  

  • 16. Implications for the FDA/Center for Veterinary Medicine (CVM).
    Geyer RE
    J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA responsibilities in regulation of drugs for use in animals: congressional perspective.
    Zeller M
    J Am Vet Med Assoc; 1993 May; 202(10):1609-12; discussion 1613-7. PubMed ID: 8514566
    [No Abstract]   [Full Text] [Related]  

  • 18. Current state of U.S. Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizon.
    Mendicino M; Fan Y; Griffin D; Gunter KC; Nichols K
    Cytotherapy; 2019 Jul; 21(7):699-724. PubMed ID: 31196820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A visit from the FDA.
    Brett J
    J Am Vet Med Assoc; 1994 May; 204(9):1319-20. PubMed ID: 8050959
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulatory issues in cell-based therapy for clinical purposes.
    Casaroli-Marano RP; Tabera J; Vilarrodona A; Trias E
    Dev Ophthalmol; 2014; 53():189-200. PubMed ID: 24732772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.